| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Taysha Gene Therapies, Inc. | CMO and Head of R&D | Common Stock | 530,589 | $864,860 | $1.63 | 06 Jul 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| TSHA | Taysha Gene Therapies, Inc. | 05 Jul 2022 | 2 | -$47,650 | 4 | CMO and Head of R&D | 07 Jul 2022, 16:30 |
| TSHA | Taysha Gene Therapies, Inc. | 29 Jun 2022 | 3 | -$183,081 | 4 | CMO and Head of R&D | 01 Jul 2022, 18:55 |
| TSHA | Taysha Gene Therapies, Inc. | 06 Apr 2022 | 1 | $0 | 4 | CMO and Head of R&D | 08 Apr 2022, 16:26 |
| TSHA | Taysha Gene Therapies, Inc. | 23 Feb 2022 | 1 | $0 | 4 | CMO and Head of R&D | 25 Feb 2022, 15:20 |
| TSHA | Taysha Gene Therapies, Inc. | 29 Jun 2021 | 7 | -$1,787,936 | 4 | CMO and Head of R&D | 01 Jul 2021, 18:32 |